SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

25 Sep 2012 07:00

RNS Number : 0548N
Rentokil Initial PLC
25 September 2012
Β 

ο»Ώ

Β 

Β 

Β 

25 September 2012

Β 

Rentokil Initial acquires the assets of Western Exterminator Company

Β 

Rentokil Initial plc ("Rentokil") (LSE: RTO) today announces that it has agreed to acquire the assets of Western Exterminator Company ("Western"), a leading pest control company on the US West Coast, for an initial cash consideration of $99.6m, with a deferred consideration of up to $15.0m payable within 18 months, from existing financial facilities.

Β 

Rentokil will become the third largest pest control company in the North American market with pro-forma annualised revenues of $330m in pest control services (with coast to coast coverage) and $90m in speciality chemical products distribution.

Β 

Western has two divisions:

Β 

Β·; The Pest Control division has 36 offices located primarily in California and the adjacent states of Arizona and Nevada. It provides Rentokil with an entrance into these states with a population of 46m people.

Β 

Β·; The Products division is a leading wholesale distributor of specialty chemicals serving the West Coast and central regions of the US, providing products and supplies to the pest control, landscape, golf course and nursery industries. This division complements our existing specialty chemical products division which serves the East Coast of the US.

Β 

The acquisition is consistent with Rentokil's strategy, outlined in November 2011, of targeting pest control acquisitions in North America, Latin America and the Middle East.

Β 

The total book value of the gross assets to be acquired is $36.7m. In the year to 31 December 2011 the business acquired generated EBITA of $4.1m on revenues of approximately $149.0m (60% Pest Control: 40% Products).

Β 

The deferred consideration will be payable subject to certain working capital and other adjustments, including warranty and/or indemnity claims.

Β 

The acquisition is expected to complete later this year subject to receipt of the relevant regulatory clearances. The transaction will be EPS accretive in year one. The profitability of Western will be improved significantly by leveraging Rentokil's commercial and operational management capabilities to bring Western's operating margins into line with Rentokil's current North American Pest Control business.

Β 

Alan Brown, Chief Executive of Rentokil Initial plc, said:

Β 

"This acquisition significantly increases Rentokil's footprint in the World's largest pest control market and enables us to compete more effectively, particularly for customers looking for nationwide coverage in pest control or specialty chemical distribution capability.

Β 

"Western has service and quality levels that are among the best in the industry. It is rightly proud of its 90-year tradition and reputation.

Β 

"We have taken our US Pest Control and Products business from revenue of less than $30million to $420million through a series of successful acquisitions, most notably JC Ehrlich, Presto-X and now Western over the last seven years."

Β 

Ends

Note: A presentation with additional information about Western Exterminator can be found at www.rentokil-initial.com/investors/presentations

Β 

About Rentokil Initial plc

Β 

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa. The Company has some 66,000 employees providing a range of support services in over 60 countries.

Β 

www.rentokil-initial.com

Β 

www.westernexterminator.com

Β 

www.target-specialty.com

Β 

Β 

Enquiries:

Β 

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 01293 858 166

Β 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Kate Holgate/ Catriona McDermott Brunswick Group 020 7404 5959

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQUVUSRUWAKURR
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.